Journal
PEDIATRIC BLOOD & CANCER
Volume 47, Issue 6, Pages 748-756Publisher
WILEY
DOI: 10.1002/pbc.20776
Keywords
acute lymphoblastic leukaemia; adolescent; survival; treatment outcome; young adult
Categories
Ask authors/readers for more resources
Adolescents and young adults (AYA) with acute lymphoblastic leukaemia (ALL) constitute a distinct population from children and older adults. Based on patterns of referral, they may be treated by either paediatric or adult oncologists. As a group, AYA with ALL have a worse survival and event-free survival (EFS) compared to that achieved by younger children. A systematic review of all published clinical trials, which provide data on treatment and outcome of adolescents with ALL, has been summarised in an effort to determine whether they should be treated on paediatric or adult type protocols. Adolescents appear to have a consistent survival advantage when treated on paediatric regimens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available